HPR17 Advancing INN-Based Prescribing in Saudi Arabia’s Private Sector: Implications for Biologics and Biosimilars Utilization Under CHI Oversight
Abstract
Authors
Shabab AlGhamdi IBRAHIM ALJUFFALI Wael Yar Mohammed Aljumah Mirna Matni Joelle Barhoun Youmna Bassil Nada Ahmed Alagil